Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Ethereum breaks through the $4,000 mark and then pulls back. Will the bull market trend continue?

Ethereum breaks through the $4,000 mark and then pulls back. Will the bull market trend continue?

2024/03/15 14:07

According to CryptoPotato, Ethereum recently broke through important resistance levels and crossed the psychological barrier of $4,000, setting a new high for the year. However, this breakout met with resistance, leading to a significant pullback. The question now is whether this pullback is just a temporary setback or the beginning of a bullish trend. Daily chart analysis shows that bullish sentiment around Ethereum remains strong, evidenced by a strong, sudden move above key resistance at $4,000. However, after briefly breaking above the key resistance at $4,000, the price came under intensifying selling pressure, possibly due to profit-taking by market participants, causing the price to fall sharply to the important support zone around $3,500. The market may find support in this area and start a new leg higher. However, in case of an ongoing pullback, Ethereum price is expected to find support near key levels of the Fibonacci retracement, specifically between the 0.5 ($3,181) and 0.618 ($2,966) levels.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny